Literature DB >> 21450636

Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure.

Ermanno Eleuteri1, Antonino Di Stefano, Franco Tarro Genta, Chiara Vicari, Isabella Gnemmi, Marilena Colombo, Alessandro Mezzani, Pantaleo Giannuzzi.   

Abstract

BACKGROUND: A reciprocal link between inflammation, oxidative/nitrosative stress, and endothelial dysfunction has been postulated in chronic heart failure (CHF). The endothelial repair mechanisms involved remain to be determined. Our aim was to investigate whether there are detectable signs of ongoing angiogenesis in serum of CHF patients and to evaluate the correlation with indexes of haemodynamic and functional impairment. METHODS AND
RESULTS: Enzyme-linked immunosorbent assay tests were used to quantify angiogenin, angiopoietin-1, angiopoietin-2, vascular endothelial growth factor, Tie-2, and brain natriuretic peptide in serum of 87 patients with CHF of increasing severity according to New York Heart Association (NYHA; class I, n = 8; II, n = 45; and III, n = 34) and in 14 healthy subjects matched for age and sex. Angiogenin, angiopoietin-2, and Tie-2 were significantly increased in CHF of increasing severity (Kruskal-Wallis: p = 0.0004, p < 0.0001, and p = 0.017, respectively). Angiopoietin-2 was inversely correlated with the 6-min walking test (r = -0.65, p < 0.0001), peak oxygen consumption (VO(2max); r = -0.57, p = 0.0002), and deceleration time (r = -0.61, p < 0.0001). Multiple regression analysis showed that angiopoietin-2 was mainly associated with VO(2max) (p = 0.018). The angiopoietin-2 area under the receiver operating characteristic curve for CHF diagnosis was 0.94 (95% CI 0.88-0.99; p < 0.001).
CONCLUSIONS: These data demonstrate that angiopoietin-2 and selected serum markers of angiogenesis progressively increase with haemodynamic and functional decline in CHF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450636     DOI: 10.1177/1741826710389410

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  20 in total

1.  Relevance of angiopoietin-2 and soluble P-selectin levels in patients with pulmonary arterial hypertension receiving combination therapy with oral treprostinil: a FREEDOM-C2 biomarker substudy.

Authors:  Manuel J Richter; Ralph Schermuly; Werner Seeger; Youlan Rao; Hossein A Ghofrani; Henning Gall
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Angiopoietin-2 and outcome in patients with acute decompensated heart failure.

Authors:  Janine Pöss; Christian Ukena; Ingrid Kindermann; Peter Ehrlich; Georg Fuernau; Sebastian Ewen; Felix Mahfoud; Steffen Kriechbaum; Michael Böhm; Andreas Link
Journal:  Clin Res Cardiol       Date:  2014-11-19       Impact factor: 5.460

3.  Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.

Authors:  Quinn S Wells; Deepak K Gupta; J Gustav Smith; Sean P Collins; Alan B Storrow; Jane Ferguson; Maya Landenhed Smith; Jill M Pulley; Sarah Collier; Xiaoming Wang; Dan M Roden; Robert E Gerszten; Thomas J Wang
Journal:  J Am Coll Cardiol       Date:  2019-05-07       Impact factor: 24.094

4.  Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension.

Authors:  Kazuyo Yamaji-Kegan; Eiki Takimoto; Ailan Zhang; Noah C Weiner; Lucas W Meuchel; Alan E Berger; Chris Cheadle; Roger A Johns
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-05-02       Impact factor: 5.464

5.  Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction.

Authors:  Seung-Jun Lee; Choong-Kun Lee; Seok Kang; Intae Park; Yoo Hyung Kim; Seo Ki Kim; Seon Pyo Hong; Hosung Bae; Yulong He; Yoshiaki Kubota; Gou Young Koh
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

6.  Angiopoietin-2 in adults with congenital heart disease and heart failure.

Authors:  Alexander Lukasz; Gernot Beutel; Philipp Kümpers; Agnieszka Denecke; Mechthild Westhoff-Bleck; Bernhard Schieffer; Johann Bauersachs; Jan T Kielstein; Oktay Tutarel
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Associations of Angiopoietins With Heart Failure Incidence and Severity.

Authors:  Brandon S Peplinski; Brian A Houston; David A Bluemke; Steven M Kawut; Todd M Kolb; Richard A Kronmal; Joao A C Lima; David D Ralph; Samuel G Rayner; Zachary L Steinberg; Ryan J Tedford; Peter J Leary
Journal:  J Card Fail       Date:  2021-04-17       Impact factor: 6.592

8.  Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.

Authors:  Courtney Premer; Arnon Blum; Michael A Bellio; Ivonne Hernandez Schulman; Barry E Hurwitz; Meela Parker; Christopher R Dermarkarian; Darcy L DiFede; Wayne Balkan; Aisha Khan; Joshua M Hare
Journal:  EBioMedicine       Date:  2015-03-28       Impact factor: 8.143

9.  Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction.

Authors:  Shaomin Chen; Lijun Guo; Baoxia Chen; Lijie Sun; Ming Cui
Journal:  Exp Ther Med       Date:  2013-01-14       Impact factor: 2.447

10.  Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction.

Authors:  Kuan-Liang Liu; Kuang-Tso Lee; Chih-Hsiang Chang; Yung-Chang Chen; Shu-Min Lin; Pao-Hsien Chu
Journal:  Crit Care       Date:  2014-05-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.